- Home
- NCTY vs MIST Comparison
NCTY vs MIST Comparison
Compare NCTY & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCTY
- MIST
- Stock Information
- Founded
- NCTY 1999
- MIST 2003
- Country
- NCTY China
- MIST Canada
- Employees
- NCTY N/A
- MIST N/A
- Industry
- NCTY Business Services
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- NCTY Consumer Discretionary
- MIST Health Care
- Exchange
- NCTY Nasdaq
- MIST Nasdaq
- Market Cap
- NCTY 121.2M
- MIST 145.3M
- IPO Year
- NCTY 2004
- MIST N/A
- Fundamental
- Price
- NCTY $10.02
- MIST $1.94
- Analyst Decision
- NCTY
- MIST Strong Buy
- Analyst Count
- NCTY 0
- MIST 3
- Target Price
- NCTY N/A
- MIST $6.33
- AVG Volume (30 Days)
- NCTY 57.4K
- MIST 1.2M
- Earning Date
- NCTY 01-01-0001
- MIST 11-11-2025
- Dividend Yield
- NCTY N/A
- MIST N/A
- EPS Growth
- NCTY N/A
- MIST N/A
- EPS
- NCTY N/A
- MIST N/A
- Revenue
- NCTY $15,305,175.00
- MIST N/A
- Revenue This Year
- NCTY N/A
- MIST N/A
- Revenue Next Year
- NCTY N/A
- MIST N/A
- P/E Ratio
- NCTY N/A
- MIST N/A
- Revenue Growth
- NCTY N/A
- MIST N/A
- 52 Week Low
- NCTY $6.28
- MIST $0.63
- 52 Week High
- NCTY $20.59
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- NCTY 55.26
- MIST 64.09
- Support Level
- NCTY $9.06
- MIST $1.75
- Resistance Level
- NCTY $11.20
- MIST $2.06
- Average True Range (ATR)
- NCTY 0.73
- MIST 0.09
- MACD
- NCTY 0.13
- MIST 0.02
- Stochastic Oscillator
- NCTY 55.13
- MIST 66.67
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).